Eye Diseases, Hereditary Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Active, not recruiting
  • Leber Congenital Amaurosis (LCA)
  • +3 more
  • AAV OPTIRPE65
  • Ann Arbor, Michigan
  • +1 more
2022-04-07
Apr 7, 2022
E
Recruiting
  • Blindness
  • +7 more
  • Miami, Florida
  • +4 more
2022-03-30
Mar 30, 2022
P
Active, not recruiting
  • Leber Congenital Amaurosis 10
  • +9 more
  • Iowa City, Iowa
  • +13 more
2022-03-02
Mar 2, 2022
N
Active, not recruiting
  • Retinitis Pigmentosa
  • +6 more
  • Gene Therapy Product-vMCO-010
  • Sham Injection
  • Beverly Hills, California
  • +6 more
2022-02-18
Feb 18, 2022
E
Recruiting
  • Blindness
  • +7 more
    • Miami, Florida
    • +6 more
    2022-01-31
    Jan 31, 2022
    P
    Active, not recruiting
    • Leber Congenital Amaurosis 10
    • +9 more
    • Iowa City, Iowa
    • +2 more
    2022-02-08
    Feb 8, 2022
    J
    Recruiting
    • Retinal Degeneration
    • +2 more
      • San Francisco, California
      • +7 more
      2022-01-12
      Jan 12, 2022
      S
      Recruiting
      • Graves Ophthalmopathy
      • +8 more
      • Doxycycline hyclate
      • Placebo
      • Guangzhou, Guangdong, China
        Zhongshan Ophthalmic Center
      2021-11-16
      Nov 16, 2021
      P
      Active, not recruiting
      • Retinitis Pigmentosa
      • +7 more
      • QR-421a
      • Sham-procedure (dose cohort 1&2 only)
      • Boston, Massachusetts
      • +6 more
      2021-09-14
      Sep 14, 2021
      P
      Recruiting
      • Autosomal Dominant Retinitis Pigmentosa
      • +7 more
      • Aurora, Colorado
      • +4 more
      2021-05-17
      May 17, 2021
      S
      Completed
      • Graves Ophthalmopathy
      • +8 more
      • Guangzhou, Guangdong, China
        Zhongshan Ophthalmic Center
      2013-12-07
      Dec 7, 2013
      H
      Completed
      • Eye Diseases, Hereditary
        • (no location specified)
        2008-12-18
        Dec 18, 2008